- Home
- MREO vs NEWT Comparison
MREO vs NEWT Comparison
Compare MREO & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- NEWT
- Stock Information
- Founded
- MREO 2015
- NEWT 1998
- Country
- MREO United Kingdom
- NEWT United States
- Employees
- MREO N/A
- NEWT N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- MREO Health Care
- NEWT Finance
- Exchange
- MREO Nasdaq
- NEWT Nasdaq
- Market Cap
- MREO 326.1M
- NEWT 316.7M
- IPO Year
- MREO N/A
- NEWT N/A
- Fundamental
- Price
- MREO $1.97
- NEWT $11.15
- Analyst Decision
- MREO Strong Buy
- NEWT Hold
- Analyst Count
- MREO 5
- NEWT 4
- Target Price
- MREO $7.40
- NEWT $13.25
- AVG Volume (30 Days)
- MREO 1.3M
- NEWT 207.0K
- Earning Date
- MREO 11-11-2025
- NEWT 11-05-2025
- Dividend Yield
- MREO N/A
- NEWT 6.81%
- EPS Growth
- MREO N/A
- NEWT 21.23
- EPS
- MREO N/A
- NEWT 2.01
- Revenue
- MREO $500,000.00
- NEWT $364,004,000.00
- Revenue This Year
- MREO N/A
- NEWT N/A
- Revenue Next Year
- MREO $72.16
- NEWT $12.40
- P/E Ratio
- MREO N/A
- NEWT $5.54
- Revenue Growth
- MREO N/A
- NEWT 20.91
- 52 Week Low
- MREO $1.47
- NEWT $9.12
- 52 Week High
- MREO $4.72
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- MREO 57.79
- NEWT 33.57
- Support Level
- MREO $1.94
- NEWT $11.13
- Resistance Level
- MREO $2.12
- NEWT $11.48
- Average True Range (ATR)
- MREO 0.11
- NEWT 0.30
- MACD
- MREO 0.02
- NEWT -0.11
- Stochastic Oscillator
- MREO 62.65
- NEWT 0.84
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.